References
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
- Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov. 2009;3(1):73–80.
- Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846–852.
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
- Kuzmich NN, Sivak KV, Chubarev VN, et al. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel). 2017;5(4):34.
- Wei Z, Wang J, Shi M, et al. Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages. Oncotarget. 2016;7(31):48995–49007. 9863.
- Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8(3):227–241.
- Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.
- Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26(3):203–234.
- Tarselli MA, Raehal KM, Brasher AK, et al. Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. Nat Chem. 2011;3(6):449–453.
- Inman M, Moody CJ. Copper(II)-mediated synthesis of indolequinones from bromoquinones and enamines. Chem Sci. 2013;4(1):29–41.
- You L, Xu Z, Punchihewa C, et al. Evaluation of a chemical library of small-molecule dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor-mediated transcription. Mol Cancer Ther. 2008;7(6):1633–1638.
- Platon M, Amardeil R, Djakovitch L, et al. Progress in palladium-based catalytic systems for the sustainable synthesis of annulated heterocycles: a focus on indole backbones. Chem Soc Rev. 2012;41(10):3929–3968.
- Humphrey GR, Kuethe JT. Practical methodologies for the synthesis of indoles. Chem Rev. 2006;106(7):2875–2911.
- Demurtas M, Baldisserotto A, Lampronti I, et al. Indole derivatives as multifunctional drugs: synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones. Bioorg Chem. 2019;85:568–576.
- Bakherad Z, Safavi M, Fassihi A, et al. Design and synthesis of novel cytotoxic Indole-Thiosemicarbazone derivatives: biological evaluation and docking study. Chem Biodiv. 2019;16(4):e1800470.
- Ferreira S, Moncada ST, Vane J. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971;231(25):237–239.
- Singh N, Bhati KS, Kumar A. Thiazolyl/oxazolyl formazanyl indoles as potent anti-inflammatory agents. Eur J Med Chem. 2008;43(11):2597–2609.
- Abo-Ashour MF, Eldehna WM, George RF, et al. Novel indole-thiazolidinone conjugates: design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents. Eur J Med Chem. 2018;160:49–60.
- Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug arbidol. Proc Natl Acad Sci USA. 2017;114(2):206–214.
- Regina GL, Coluccia A, Brancale A, et al. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideJ. J Med Chem. 2011;54(6):1587–1598.
- Yadav BP, Ahmad I, Thakur MIJ. Synthesis of some novel indole derivatives aspotential antibacterial, antifungal and antimalarial agents. IOSR J Pharm. 2016;6:27. http://www.iosrphr.org/papers/v6i10V3/D0610032733.
- Stec J, Onajole OK, Lun S, et al. Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection. J Med Chem. 2016;59(13):6232–6247.
- Mahboobi S, Pongratz H, Hufsky H, et al. Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem. 2001;44(26):4535–4553.
- Vankadar N. Arbidol: a potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int J Antimicrob Agents. 2020;56:105998.
- Wang X, Cao R, Zhang H, et al. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020;6:28.
- Di Q, Zhu H, Pu D, et al. The natural compound cirsitakaoside enhances antiviral innate responses against vesicular stomatitis virus in vitro and in vivo. Int Immunopharmacol. 2020;86:106783.
- Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585.
- Weiss U. Inflammation. Nature. 2008;454(7203):427.
- Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111(2):S460–S475.
- Costela-Ruiz V’I. J, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Fact Rev. 2020;54:62–75.
- de Pádua Lúcio K, Silveira Rabelo AC, Araújo CM, et al. Anti-Inflammatory and antioxidant properties of black mulberry (morus nigra L.) in a model of LPS-Induced sepsis. Oxid Med Cell Longev. 2018;2018:5048031.
- Cheng N, Liang Y, Du X, et al. Serum amyloid a promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep. 2018;19(10):e45517.
- Gliozzi M, Gliozzi M, Gliozzi M, et al. Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development. Int J Mol Sci. 2019;20(13):3294.
- Echizen K, Hirose O, Maeda Y, et al. Inflammation in gastric cancer: interplay of the COX-2/prostaglandin E2 and toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107(4):391–397. Apr
- DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379–400.
- Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 2005;7(8):758–765.
- Jha P, Das H. KLF2 in regulation of NF-κB-Mediated immune cell function and inflammation. Int J Mol Sci. 2017;18(11):2383. 18112383.
- Sandes SMS, Heimfarth L, Brito RG, et al. Evidence for the involvement of TNF-α, IL-1β and IL-10 in the antinociceptive and anti-inflammatory effects of indole-3-guanylhydrazone hydrochloride, an aromatic aminoguanidine, in rodents. Chem Biol Interact. 2018;286:1–10.
- O’Neill LAJ, Bowie AG. The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol. 2007;7(5):353–364.